Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - paracetamol, quantity: 325 mg; tramadol hydrochloride, quantity: 37.5 mg - tablet, film coated - excipient ingredients: powdered cellulose; magnesium stearate; macrogol 6000; sodium starch glycollate type a; titanium dioxide; hypromellose; pregelatinised maize starch; purified talc; iron oxide yellow; lactose monohydrate; maize starch; propylene glycol - zaldiar is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - tramadol hydrochloride, quantity: 37.5 mg; paracetamol, quantity: 325 mg - tablet, effervescent - excipient ingredients: povidone; sunset yellow fcf; saccharin sodium; citric acid; sodium bicarbonate; macrogol 6000; acesulfame potassium; sodium dihydrogen citrate; colloidal anhydrous silica; magnesium stearate; flavour - zaldiar is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Israel - English - Ministry of Health

tec-o-pharm-libra ltd - paracetamol; tramadol hydrochloride - film coated tablets - paracetamol 325 mg; tramadol hydrochloride 37.5 mg - paracetamol - paracetamol - symptomatic treatment of moderate to severe pain.the use of zaldiar should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - tramadol hydrochloride; paracetamol -